awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26993238-B8EC57B8-E05A-41D8-900F-DB8FE8C0F8D8
Q26993238-B8EC57B8-E05A-41D8-900F-DB8FE8C0F8D8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26993238-B8EC57B8-E05A-41D8-900F-DB8FE8C0F8D8
Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapy
P2860
Q26993238-B8EC57B8-E05A-41D8-900F-DB8FE8C0F8D8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26993238-B8EC57B8-E05A-41D8-900F-DB8FE8C0F8D8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
12c5f50374fd0176a012dd4f82dbd5c3edde682e
P2860
A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors.